Medicamen Biotech consolidated net profit declines 36.89% in the December 2025 quarter
Sales rise 3.92% to Rs 46.91 crore
Net profit of Medicamen Biotech declined 36.89% to Rs 2.19 crore in the quarter ended December 2025 as against Rs 3.47 crore during the previous quarter ended December 2024. Sales rose 3.92% to Rs 46.91 crore in the quarter ended December 2025 as against Rs 45.14 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales46.9145.14 4 OPM %9.3414.86 -PBDT3.946.09 -35 PBT2.113.88 -46 NP2.193.47 -37Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 14 2026 | 9:06 AM IST